Package 68071-3434-0

{"route": ["ORAL"], "spl_id": "2d58716c-2371-b0e1-e063-6294a90a408e", "openfda": {"upc": ["0368071343403"], "unii": ["V3888OEY5R"], "rxcui": ["897683"], "spl_set_id": ["fe0583bf-9986-e01e-e053-6294a90a0b26"], "manufacturer_name": ["NuCare Pharmaceuticals,Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68071-3434-0)", "package_ndc": "68071-3434-0", "marketing_start_date": "20230608"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "68071-3434_2d58716c-2371-b0e1-e063-6294a90a408e", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "68071-3434", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "NuCare Pharmaceuticals,Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "80 mg/1"}], "application_number": "ANDA071881", "marketing_category": "ANDA", "marketing_start_date": "20110107", "listing_expiration_date": "20261231"}